Cargando…
Sustainably released nanoparticle-based rhynchophylline limits pulmonary fibrosis by inhibiting the TEK-PI3K/AKT signaling pathway
BACKGROUND: Pulmonary fibrosis (PF) is a rapidly progressing and irreversible disease, and the currently available types of clinical drugs are limited and inefficient. In our previous study, we observed that Rhynchophylline (Rhy) hindered tendon adhesion and stimulated the healing of injured tendon...
Autores principales: | Wang, Shuo, Huang, Zhanghao, Liu, Yifei, Sun, Hui, Zhou, Youlang, Shi, Jiahai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10087999/ https://www.ncbi.nlm.nih.gov/pubmed/37057119 http://dx.doi.org/10.21037/tlcr-22-675 |
Ejemplares similares
-
Rhynchophylline Ameliorates Endothelial Dysfunction via Src-PI3K/Akt-eNOS Cascade in the Cultured Intrarenal Arteries of Spontaneous Hypertensive Rats
por: Hao, Hui-Feng, et al.
Publicado: (2017) -
PRKCB is relevant to prognosis of lung adenocarcinoma through methylation and immune infiltration
por: Wang, Jinjie, et al.
Publicado: (2022) -
Cellular Effects of Rhynchophylline and Relevance to Sleep Regulation
por: Ballester Roig, Maria Neus, et al.
Publicado: (2021) -
StorageTek T10000 Tape Cartridge
Publicado: (1985) -
Swedish snus and the GothiaTek(® )standard
por: Rutqvist, Lars E, et al.
Publicado: (2011)